Literature DB >> 11732288

[Molecular studies in a population of children with bronchial asthma. I. Polymorphism in the promotor region of gene CD14].

G Lis1, E Kostyk, M Sanak, J J Pietrzyk.   

Abstract

UNLABELLED: Allergic asthma is associated with the recruitment of the inflammatory cells into the bronchial mucosa. Surface expression of CD14, a marker of activation and differentiation of macrophages/monocytes, was suggested to protect against Th-2 response.
OBJECTIVE: To investigate clinical effects of genetic polymorphism of CD14 promoter in asthmatic children.
METHODS: In ISAAC survey, 50 children with asthma were identified (wheezing in the last year, serum IgE level > 150 kIU/l, positive bronchial challenge test with aerolized hypertonic saline) and 73 children without the above signs. Age range of surveyed children was 13-14 years. Genotypic pattern of CD14 promoter -159 C to T transition was assessed by RFLP method.
RESULTS: There was no difference in the allelic (0.36 vs. 0.38 for -159T) or genotype frequencies (0.12 vs. 0.15 for -159TT) of CD14 polymorphism between allergic asthmatics and controls. Moreover, there was no relationship between CD14 genotype and serum IgE level or bronchial hyper-responsiveness.
CONCLUSION: Our results do not confirm the association of CD14 polymorphism (promoter -159 C to T transition) with asthma in Polish children.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11732288

Source DB:  PubMed          Journal:  Pneumonol Alergol Pol        ISSN: 0867-7077


  8 in total

1.  No Association Between -159C/T Polymorphism of the CD14 Gene and Asthma Risk: a Meta-Analysis of 36 Case-Control Studies.

Authors:  Rui Zhang; Rui Deng; He Li; Hong Chen
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

2.  Association study using combination analysis of SNP and STRP markers: CD14 promoter polymorphism and IgE level in Taiwanese asthma children.

Authors:  Jiu-Yao Wang; Ling-Mei Wang; Cherry Guan-Ju Lin; Ashely Ching-Wei Chang; Lawrence Shih-Hsin Wu
Journal:  J Hum Genet       Date:  2004-12-16       Impact factor: 3.172

3.  The CD14 C-159T polymorphism is not associated with asthma or asthma severity in an Australian adult population.

Authors:  M-A Kedda; F Lose; D Duffy; E Bell; P J Thompson; J Upham
Journal:  Thorax       Date:  2005-03       Impact factor: 9.139

Review 4.  Toll-like receptors and immune response in allergic disease.

Authors:  Sophie C Gangloff; Moncef Guenounou
Journal:  Clin Rev Allergy Immunol       Date:  2004-04       Impact factor: 8.667

5.  Racial differences in the association of CD14 polymorphisms with serum total IgE levels and allergen skin test reactivity.

Authors:  Zongyao Wang; John S Sundy; Catherine M Foss; Huiman X Barnhart; Scott M Palmer; Sallie D Allgood; Evan Trudeau; Katie M Alexander; Marc C Levesque
Journal:  J Asthma Allergy       Date:  2013-06-25

Review 6.  Association of CD14 -260 (-159) C>T and asthma: a systematic review and meta-analysis.

Authors:  Linlu Zhao; Michael B Bracken
Journal:  BMC Med Genet       Date:  2011-07-11       Impact factor: 2.103

7.  A systematic review of CD14 and toll-like receptors in relation to asthma in Caucasian children.

Authors:  Ester Mm Klaassen; Brenda Ejt Thönissen; Guillaume van Eys; Edward Dompeling; Quirijn Jöbsis
Journal:  Allergy Asthma Clin Immunol       Date:  2013-03-15       Impact factor: 3.406

8.  Association of CD14 -159 (-260C/T) polymorphism and asthma risk: an updated genetic meta-analysis study.

Authors:  Duan Wang; Yang Yang; Jin Xu; Zong-Ke Zhou; Hai-Yang Yu
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.